This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Following research at Imperial College, we believe we’ve found a novel and effective treatment for relapsed/resistant cancer, targeting and killing cancer stem cells. With patents in place, we now need funding for the next phase: to complete lab-testing prior to clinical trials.

  • Amount raised (£)

    £258,086.90

  • Company number

    10502511

  • Incorporation date

    29/11/2016

  • Total investors

    817

Details

  • Company number

    10502511

  • Incorporation date

    29/11/2016

  • Company status

    Active

  • Industry type

    Research and experimental development on biotechnology

  • Number of current appointments

    3

56 Haverstock Hill Haverstock Hill
London
NW3 2BH

Crowdcube Funding History

Date Amount No. of Investors
06/08/2020 £258,086.90 817 View
Date Description Type
29/09/2020

Memorandum and Articles of Association

PDF
29/09/2020

Resolutions

PDF
29/07/2020

Resolutions

PDF

People

Name Role Appointed Nationality
COHEN, Laurence John Director 17/05/2017 British
DEONARAIN, Mahendra Persaud, Dr Director 19/04/2019 British
EPENETOS, Agamemnon Antoniou, Dr Director 16/11/2016 British